295 related articles for article (PubMed ID: 24437492)
41. Development of the osteoblast phenotype in primary human osteoblasts in culture: comparison with rat calvarial cells in osteoblast differentiation.
Siggelkow H; Rebenstorff K; Kurre W; Niedhart C; Engel I; Schulz H; Atkinson MJ; Hüfner M
J Cell Biochem; 1999 Oct; 75(1):22-35. PubMed ID: 10462701
[TBL] [Abstract][Full Text] [Related]
42. Kruppel-Like Factor 4 represses osteoblast differentiation via ciliary Hedgehog signaling.
Takeuchi Y; Kito A; Itoh S; Naruse H; Fujikawa J; Sadek KM; Akiyama S; Yamashiro T; Wakisaka S; Abe M
Exp Cell Res; 2018 Oct; 371(2):417-425. PubMed ID: 30193838
[TBL] [Abstract][Full Text] [Related]
43. Chemical inhibitors of c-Met receptor tyrosine kinase stimulate osteoblast differentiation and bone regeneration.
Kim JW; Lee MN; Jeong BC; Oh SH; Kook MS; Koh JT
Eur J Pharmacol; 2017 Jul; 806():10-17. PubMed ID: 28322831
[TBL] [Abstract][Full Text] [Related]
44. Untargeted metabolomics in primary murine bone marrow stromal cells reveals distinct profile throughout osteoblast differentiation.
Misra BB; Jayapalan S; Richards AK; Helderman RCM; Rendina-Ruedy E
Metabolomics; 2021 Sep; 17(10):86. PubMed ID: 34537901
[TBL] [Abstract][Full Text] [Related]
45. Ets transcription factors and targets in osteogenesis.
Raouf A; Seth A
Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
[TBL] [Abstract][Full Text] [Related]
46. Lower bone cellular activities in male and female mature C3H/HeJ mice are associated with higher bone mass and different pyridinium crosslink profiles compared to C57BL/6J mice.
Amblard D; Lafage-Proust MH; Chamson A; Rattner A; Collet P; Alexandre C; Vico L
J Bone Miner Metab; 2003; 21(6):377-87. PubMed ID: 14586794
[TBL] [Abstract][Full Text] [Related]
47. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro.
Saleh H; Eeles D; Hodge JM; Nicholson GC; Gu R; Pompolo S; Gillespie MT; Quinn JM
Endocrinology; 2011 May; 152(5):1911-22. PubMed ID: 21363931
[TBL] [Abstract][Full Text] [Related]
48. Enhancement of osteogenesis in vitro and in vivo by a novel osteoblast differentiation promoting compound, TAK-778.
Notoya K; Nagai H; Oda T; Gotoh M; Hoshino T; Muranishi H; Taketomi S; Sohda T; Makino H
J Pharmacol Exp Ther; 1999 Sep; 290(3):1054-64. PubMed ID: 10454478
[TBL] [Abstract][Full Text] [Related]
49. Active mitochondria support osteogenic differentiation by stimulating β-catenin acetylation.
Shares BH; Busch M; White N; Shum L; Eliseev RA
J Biol Chem; 2018 Oct; 293(41):16019-16027. PubMed ID: 30150300
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
[TBL] [Abstract][Full Text] [Related]
51. Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization.
Brandao-Burch A; Utting JC; Orriss IR; Arnett TR
Calcif Tissue Int; 2005 Sep; 77(3):167-74. PubMed ID: 16075362
[TBL] [Abstract][Full Text] [Related]
52. Tensile stress induces bone morphogenetic protein 4 in preosteoblastic and fibroblastic cells, which later differentiate into osteoblasts leading to osteogenesis in the mouse calvariae in organ culture.
Ikegame M; Ishibashi O; Yoshizawa T; Shimomura J; Komori T; Ozawa H; Kawashima H
J Bone Miner Res; 2001 Jan; 16(1):24-32. PubMed ID: 11149486
[TBL] [Abstract][Full Text] [Related]
53. Spontaneous fractures in the mouse mutant sfx are caused by deletion of the gulonolactone oxidase gene, causing vitamin C deficiency.
Mohan S; Kapoor A; Singgih A; Zhang Z; Taylor T; Yu H; Chadwick RB; Chung YS; Donahue LR; Rosen C; Crawford GC; Wergedal J; Baylink DJ
J Bone Miner Res; 2005 Sep; 20(9):1597-610. PubMed ID: 16059632
[TBL] [Abstract][Full Text] [Related]
54. BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b.
Kokabu S; Gamer L; Cox K; Lowery J; Tsuji K; Raz R; Economides A; Katagiri T; Rosen V
Mol Endocrinol; 2012 Jan; 26(1):87-94. PubMed ID: 22074949
[TBL] [Abstract][Full Text] [Related]
55. PPARδ-mediated mitochondrial rewiring of osteoblasts determines bone mass.
Müller DIH; Stoll C; Palumbo-Zerr K; Böhm C; Krishnacoumar B; Ipseiz N; Taubmann J; Zimmermann M; Böttcher M; Mougiakakos D; Tuckermann J; Djouad F; Schett G; Scholtysek C; Krönke G
Sci Rep; 2020 May; 10(1):8428. PubMed ID: 32439961
[TBL] [Abstract][Full Text] [Related]
56. PTH/PTHrP receptor is temporally regulated during osteoblast differentiation and is associated with collagen synthesis.
McCauley LK; Koh AJ; Beecher CA; Cui Y; Rosol TJ; Franceschi RT
J Cell Biochem; 1996 Jun; 61(4):638-47. PubMed ID: 8806088
[TBL] [Abstract][Full Text] [Related]
57. Gene array profile identifies collagen type XV as a novel human osteoblast-secreted matrix protein.
Lisignoli G; Codeluppi K; Todoerti K; Manferdini C; Piacentini A; Zini N; Grassi F; Cattini L; Piva R; Rizzoli V; Facchini A; Giuliani N; Neri A
J Cell Physiol; 2009 Aug; 220(2):401-9. PubMed ID: 19365806
[TBL] [Abstract][Full Text] [Related]
58. Inbred strain-specific response to biglycan deficiency in the cortical bone of C57BL6/129 and C3H/He mice.
Wallace JM; Golcuk K; Morris MD; Kohn DH
J Bone Miner Res; 2009 Jun; 24(6):1002-12. PubMed ID: 19113913
[TBL] [Abstract][Full Text] [Related]
59. Bioenergetic Metabolism In Osteoblast Differentiation.
Shen L; Hu G; Karner CM
Curr Osteoporos Rep; 2022 Feb; 20(1):53-64. PubMed ID: 35112289
[TBL] [Abstract][Full Text] [Related]
60. von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation.
Bonewald LF; Harris SE; Rosser J; Dallas MR; Dallas SL; Camacho NP; Boyan B; Boskey A
Calcif Tissue Int; 2003 May; 72(5):537-47. PubMed ID: 12724828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
